156 related articles for article (PubMed ID: 22080567)
1. Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer.
Bertini I; Cacciatore S; Jensen BV; Schou JV; Johansen JS; Kruhøffer M; Luchinat C; Nielsen DL; Turano P
Cancer Res; 2012 Jan; 72(1):356-64. PubMed ID: 22080567
[TBL] [Abstract][Full Text] [Related]
2. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ
J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556
[TBL] [Abstract][Full Text] [Related]
3. Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
Napoli C; Sperandio N; Lawlor RT; Scarpa A; Molinari H; Assfalg M
J Proteome Res; 2012 Feb; 11(2):1274-83. PubMed ID: 22066465
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic profiling of Aurora kinase B is associated with overall survival in metastatic colorectal cancer.
Pohl A; Azuma M; Zhang W; Yang D; Ning Y; Winder T; Danenberg K; Lenz HJ
Pharmacogenomics J; 2011 Apr; 11(2):93-9. PubMed ID: 20368716
[TBL] [Abstract][Full Text] [Related]
6. Metastatic lymph node size and colorectal cancer prognosis.
Dhar DK; Yoshimura H; Kinukawa N; Maruyama R; Tachibana M; Kohno H; Kubota H; Nagasue N
J Am Coll Surg; 2005 Jan; 200(1):20-8. PubMed ID: 15631916
[TBL] [Abstract][Full Text] [Related]
7. Analysis of metabolomic data using support vector machines.
Mahadevan S; Shah SL; Marrie TJ; Slupsky CM
Anal Chem; 2008 Oct; 80(19):7562-70. PubMed ID: 18767870
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.
Sorbye H; Pfeiffer P; Cavalli-Björkman N; Qvortrup C; Holsen MH; Wentzel-Larsen T; Glimelius B
Cancer; 2009 Oct; 115(20):4679-87. PubMed ID: 19562777
[TBL] [Abstract][Full Text] [Related]
9. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
10. Metabolite profiling of fecal water extracts from human colorectal cancer.
Monleón D; Morales JM; Barrasa A; López JA; Vázquez C; Celda B
NMR Biomed; 2009 Apr; 22(3):342-8. PubMed ID: 19006102
[TBL] [Abstract][Full Text] [Related]
11. Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification.
Bertram HC; Eggers N; Eller N
Anal Chem; 2009 Nov; 81(21):9188-93. PubMed ID: 19780580
[TBL] [Abstract][Full Text] [Related]
12. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
13. Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.
Efficace F; Innominato PF; Bjarnason G; Coens C; Humblet Y; Tumolo S; Genet D; Tampellini M; Bottomley A; Garufi C; Focan C; Giacchetti S; Lévi F;
J Clin Oncol; 2008 Apr; 26(12):2020-6. PubMed ID: 18421055
[TBL] [Abstract][Full Text] [Related]
14. Pattern of relapse after curative surgery for metastatic colorectal cancer.
You JJ; Chen HC; Chen HJ; Hsieh CS; Chang MC; Yu JH; Chen YL; Chang CS
Saudi Med J; 2011 Sep; 32(9):907-12. PubMed ID: 21894352
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer: the potential of metabolic fingerprinting.
Turano P
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):847-9. PubMed ID: 25109498
[TBL] [Abstract][Full Text] [Related]
16. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis.
OuYang D; Xu J; Huang H; Chen Z
Appl Biochem Biotechnol; 2011 Sep; 165(1):148-54. PubMed ID: 21505807
[TBL] [Abstract][Full Text] [Related]
18. A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer.
Jobard E; Pontoizeau C; Blaise BJ; Bachelot T; Elena-Herrmann B; Trédan O
Cancer Lett; 2014 Feb; 343(1):33-41. PubMed ID: 24041867
[TBL] [Abstract][Full Text] [Related]
19. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.
Jiménez B; Montoliu C; MacIntyre DA; Serra MA; Wassel A; Jover M; Romero-Gomez M; Rodrigo JM; Pineda-Lucena A; Felipo V
J Proteome Res; 2010 Oct; 9(10):5180-7. PubMed ID: 20690770
[TBL] [Abstract][Full Text] [Related]
20. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
